Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors

NCT00415103

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Hospital Universitario Gregorio Marañón Madrid, Spain
  • Hospital Universitario La Paz Madrid, Spain
  • Hospital Universitario la Princesa Madrid, Spain
  • Hospital Clínico Universitario de Salamanca Salamanca, Spain
View Trial Details
Completed

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

NCT00345189

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Research site Scottsdale, Arizona, United States
  • Research site New Haven, Connecticut, United States
  • Research site San Antonio, Texas, United States
  • Research site Sutton, Surrey, United Kingdom
View Trial Details
Completed

Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

NCT00070083

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
  • Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada
  • British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

NCT00088101

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +15 more
Locations
  • Wilshire Oncology Medical Group Pomona, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Tufts New England Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions